-
Article | 2025.03.10
Monitoring sensitive situations and providing support
Some situations require closer monitoring, either when requested by a funder or because they represent a specific risk (for example a health or environmental risk or a conflict of interest). In these cases, the Institut Pasteur supports the teams concerned via two permanent operational groups: the Dual Use Liaison Group (DULG) and the Conflict of Interest Review Board (GELI). An ad hoc committee...
-
Article | 2025.03.10
Observing standards of professional conduct and scientific integrity
Guaranteeing the scientific integrity, compliance and impartiality of research is crucial, especially at a time when scientific methods and findings are coming under increasing public scrutiny. At the Institut Pasteur, the Research Integrity Officer (RIS) works with the Committee for Research Integrity and Conciliation (CISC) and the Ethics and Compliance Committee (CDC) to oversee compliance...
-
Vidéo | 2025.03.24
Understanding depression
30% of people suffering from depression are resistant to antidepressants. Why?With her team, Mariana Alonso, a researcher in the Perception and Action Unit and head of the Emotional Circuits team at the Institut Pasteur, has identified a key mechanism involved in this disorder. During a depressive episode, the amygdala, a region of the brain that processes emotions, functions differently:Less...
-
News | 2025.03.26
Training the Physician-Scientists of Tomorrow: Institut Pasteur MD-PhD Program
In the face of global health crises and growing public health challenges, strengthening the links between scientific research (both fundamental and applied) and clinical practice has become essential. Recognizing this need, the Institut Pasteur has launched the MD-PhD program as part of its “Pasteur 2030” strategic plan, aiming to engage the Institute in training physician-scientists who can...
-
News | 2025.03.20
An international scientific alliance to strengthen the fight against infectious diseases
The Institut Pasteur and UCSF-QBI celebrated an ongoing successful scientific collaboration today, which was initiated in March 2019, and expanded significantly during the pandemic. This alliance, formalized in October 2022, aimed at bolstering the fight against infectious diseases, has already spawned more than 20 research projects, a dozen publications in high-level journals, and numerous...
-
Document de presse | 2025.03.06
How AI will make it easier to anticipate future pandemics
In a Nature perspective paper, scientists across Africa, America, Asia, Australia, and Europe outline for the first time how Artificial Intelligence (AI) can transform the landscape of infectious disease research and improve pandemic preparedness. In the next five years, integrating AI into country response systems could save more lives by anticipating the location and trajectory of disease...
-
Article | 2020.08.13
The Institut Pasteur Innovation Accelerator
The main challenge for academics in the commercialization of important new discoveries is the technological development gap: the phase between inventions at an early stage and the stage that innovative technologies must reach to become viable and attractive candidates for licensing and commercialization.For high risk/high value products or for products with low commercial profitability, it is...
-
Vidéo | 2025.04.04
Debunking meningitis
Meningitis: warning signs!200 cases in France since January? Yes, but... This figure concerns invasive meningococcal infections, a 25-year record. But not all of them are meningitis!Dr Samy Taha, medical researcher at the CNR des Méningocoques, reminds us of the importance of prevention and rapid screening to limit serious forms of the disease.Symptoms to watch out for :High fever and intense...
-
Vidéo | 2025.04.07
The comeback of measles
Measles explodes in 2025: what do we do?Nearly 200 cases in France this year, twice as many as last year! This ultra-contagious virus infects the respiratory tract before spreading throughout the body. 1 patient can infect 20 - as easily as a cold! Fever, cough, rash... but above all serious complications for 1 in 5 people: pneumonia, encephalitis, hospitalization, and babies at risk. Over a...
-
Article | 2025.02.27
Ludwig Maximilian University of Munich
Through a partnership between Ludwig Maximilian University (LMU) of Munich and the Institut Pasteur, outstanding medical students can pursue hands-on research in Paris. This unique framework, part of the Institut Pasteur MD-PhD program and the LMU StEP program, enriches clinical training with cutting-edge biomedical research.
